Publication Name	World Journal of Diabetes
Manuscript ID	5792
Country	China

Received	2013-09-26 20:46
Peer-Review Started	2013-09-27 14:01
To Make the First Decision	2013-10-28 16:07
Return for Revision	2013-10-30 11:18
Revised	2013-11-19 13:31
Second Decision	2014-05-08 17:44
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2014-05-08 18:00
Articles in Press	2014-05-23 09:16
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2014-06-13 21:03
Publish the Manuscript Online	2014-06-16 15:44

ISSN	1948-9358 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Endocrinology & Metabolism
Manuscript Type	Review
Article Title	Adrenomedullin and diabetes
Manuscript Source	Invited Manuscript
All Author List	Hoi Kin Wong, Fai Tang, Tsang Tommy Cheung and Bernard Man Yung Cheung
Funding Agency and Grant Number	Funding Agency Grant Number University of Hong Kong Seed Funding Program for Basic Research 201111159132 Sun Chieh Yeh Heart Foundation
Corresponding Author	Bernard Man Yung Cheung, PhD, FRCP, Professor of Department of Medicine, Queen Mary Hospital, 102, Pokfulam Road, Hong Kong, China. mycheung@hku.hk
Key Words	Adrenomedullin; Diabetes; Diabetic complications; Hyperglycemia; Therapeutics
Core Tip	Adrenomedullin (ADM) is a peptide hormone with vasorelaxing and hypotensive properties. It also plays multiple roles in the regulation of hormonal secretion, glucose metabolism and inflammatory response. A major observation is the elevation of plasma ADM level in diabetes, and is associated with diabetic complications in both type 1 and 2 diabetes. The increase could be resulted from oxidative stress, hyperinsulinemia and endothelial injury. This raises the potential application of ADM as a marker in diabetes, and strategies aimed at reducing ADM level could be explored so as to alleviate diabetic complications.
Publish Date	2014-06-16 15:44
Citation	Wong HK, Tang F, Cheung TT, Cheung BMY. Adrenomedullin and diabetes. World J Diabetes 2014; 5(3): 364-371
URL	http://www.wjgnet.com/1948-9358/full/v5/i3/364.htm
DOI	http://dx.doi.org/10.4239/wjd.v5.i3.364

Full Article (PDF)	WJD-5-364.pdf
Full Article (Word)	WJD-5-364.doc
Manuscript File	5792-Review.doc
Answering Reviewers	5792-Answering reviewers.pdf
Copyright License Agreement	5792-Copyright assignment.pdf
Peer-review Report	5792-Peer review(s).pdf
Scientific Editor Work List	5792-Scientific editor work list.pdf